Fareeda Y. Coxon

机构：Newcastle upon Tyne Hospitals NHS Foundation Trust

发表论文 47 篇 · 总被引 6958 次 · h-index 23

代表论文

• Capecitabine and Oxaliplatin for Advanced Esophagogastric Cancer (2008 · New England Journal of Medicine · 被引 2325)
• Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study (2019 · The Lancet Oncology · 被引 1277)
• Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial (2013 · The Lancet Oncology · 被引 732)
• Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trial (2013 · The Lancet Oncology · 被引 610)
• Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial (2014 · The Lancet Oncology · 被引 379)
• Peri-operative chemotherapy with or without bevacizumab in operable oesophagogastric adenocarcinoma (UK Medical Research Council ST03): primary analysis results of a multicentre, open-label, randomised phase 2–3 trial (2017 · The Lancet Oncology · 被引 292)